SynCore Biotechnology Competitors and Similar CompaniesClear all
SynCore Biotechnology's competitors and similar companies include RenovoRx.
 SynCore Biotechnology SynCoreBio (杏國新藥股份有限公司) is a biopharmaceutical company engaged in the research and development of drugs with a focus on oncology, ophthalmology, dermatology, and infectious diseases. |  RenovoRx RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors. | |
Founding Date | Founding Date 2008 | Founding Date 2012 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations TW HQ | Locations Los Altos, US HQ |
Employees | Employees 40 | Employees 7 |
Financial | ||
Revenue (est.) | Revenue (est.) NT$23.3m (FY, 2024) | Revenue (est.) $1.1m (FY, 2025) |
Cost of goods | Cost of goods NT$10.5m (FY, 2024) | Cost of goods $327k (FY, 2025) |
Gross profit | Gross profit NT$12.9m (FY, 2024) | Gross profit $796k (FY, 2025) |
Net income | Net income (NT$54.3m) (FY, 2024) | Net income ($11.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
RenovoRx
HQ
Los Altos, US
Employees
7
RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors.
View company